

Ceftriaxone Sulbactam Injection (PCD PHARMA FRANCHIES)
₹ 165/Vial
| Composition Ratio | 1.5 |
| Usage | Treats various bacterial infections |
| Usage / Application | Human Use |
| Brand | CEFGIRI-1.5GM |
| Strength | 1.5 gm |
| Pack Type | Vial |
| Dose | 1000/500MG |
| Composition | Ceftriaxonen 1000mg + Sulbactam 500mg |
| Composition (Ceftriaxone/Sulbactam) | 1000mg/500mg |
| Packaging Content | Vial with WFI |
| Packaging Size | 1.5GM |
| Route of Administration | For IM/IV Use |
| Injection Type | ANTIBIOTIC |
| Brand Name | CEFGIRI-1.5GM |
| Manufacturer | GIRIPRIYA |
| Packaging Type | VIAL |
| Manufactured By | GIRIPRIYA |
| Form | Powder for Inj |
| Pharmacopoeia Standard | IP |
| Usage/Application | eftriaxone+sulbactam injection is prescribed for various bacterial infections caused by susceptible |
| Shelf Life | 24 Months |
| Injection Site | Intramuscular, Intravenous |
| Prescription Status | Prescription |
| Medicine Type | API |
| Prescription/Non prescription | PRESCRIPTION |
| Country of Origin | Made in India |
| Availability | In Stock |
| View in Hindi | सेफ़्ट्रियाक्सोन सुल्बैक्टम इंजेक्शन (पीसीडी फार्मा फ्रैंचाइज़ी), स्ट्रेंथ: 1.5 जीएम |
Find related categories
Shipping Information
| Price | Excluding all taxes |
| Ships from | Kurukshetra |
| Shipping | As per delivery location |
Product Image




About the Company
- GST Registration Date
- Feb 2026
- Legal Status of Firm
- Partnership
- Nature of Business
- Service Provider and Others
- Number of Employees
- Upto 10 People
- IndiaMART Member Since
- Sept 2024
- GST
- 06**********1ZR
Giripriya Pharma Pvt. Ltd. is the industry-leading are Manufacturer and Service Provider firm commenced its business operations in the year 2024 to bring forth best quality Pharmaceutical Tablets, Syrup, Capsules, Liver Tonic, PCD Pharma Franchise and many more. Our offered range of high-quality products is manufactured by utilizing carefully selected inventory of raw materials to render beneficial attributes of robust quality construction and competitive price ban.







